InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold Post author:Sam Post published:March 27, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AbbVie's $175 Million Gamble Pays Off as Ablynx RA Drug Meets Goal in Phase II Study July 8, 2016 Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017 Media Mogul Dumps $125 Million Theranos Stake for $1 March 26, 2017
Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017